Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Hypertension. 2010 Mar 8;55(5):1199–1205. doi: 10.1161/HYPERTENSIONAHA.109.149153

Table 4.

Serum lipids before and after treatment

Treatment Group P-value from pairwise comparison after treatment

Variable DASH-WM DASH-A UC DASH-WM vs. DASH-A DASH-WM vs. UC DASH-A vs UC
Total Cholesterol (mg/dl) Before 209 (198, 220) 199 (188, 211) 206 (195, 217)
After 184 (177, 199) 199 (192, 205) 205 (199, 211) .008 < .001 .364
Low Density Lipoprotein-Cholesterol (mg/dl) Before 128 (118, 138) 122 (112, 132) 126 (116, 136)
After 112 (106, 117) 122 (116, 127) 125 (119, 130) .054 .005 .715
High Density Lipoprotein-Cholesterol (mg/dl) Before 55 (50, 59) 53 (49, 57) 55 (51, 59)
After 54 (52, 55) 51 (50, 53) 54 (53, 56) .115 .911 .047
Triglycerides (mg/dl) Before 133 (116, 149) 122 (106, 139) 122 (106, 139)
After 93 (81, 106) 129 (117, 142) 130 (118, 142) < .001 < .001 .900

Values are mean and 95% confidence interval. Values after treatment are adjusted for pretreatment levels of outcome variable, age, gender, and ethnicity. P-values are adjusted using Tukey’s Honestly Significant Difference procedure.